LogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic Acidemia

Stock Information for ContextLogic Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ContextLogic Inc.

ContextLogic to Announce First Quarter 2025 Results on May 9, 2025
ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results
ContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025
ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners
ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
ContextLogic Inc. Reports Second-Quarter Financial Results
LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, JVA, AKUS, LOGC

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.